COGT Return on Tangible Equity | Cogent Biosciences, Inc.

Cogent Biosciences, Inc. (COGT) Return on Tangible Equity

2026-06-30: Return Tang Equity -70.85%.
2026-03-31: Return Tang Equity -58.30%.
2025-12-31: Return Tang Equity -51.69%.
2025-09-30: Return Tang Equity -97.32%.

Complete source-backed return tang equity history.

Available history: 2017-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-70.85%
2026-03-31	-58.30%
2025-12-31	-51.69%
2025-09-30	-97.32%
2025-06-30	-183.23%
2025-03-31	-123.06%
2024-12-31	-99.83%
2024-09-30	-77.00%
2024-06-30	-60.83%
2024-03-31	-50.24%
2023-12-31	-74.63%
2023-09-30	-58.65%
2023-06-30	-45.16%
2023-03-31	-66.29%
2022-12-31	-54.84%
2022-09-30	-43.30%
2022-06-30	-34.30%
2022-03-31	-48.53%
2021-12-31	-33.74%
2021-09-30	-29.76%
2021-06-30	-42.10%
2021-03-31	-35.47%
2020-12-31	-31.88%
2020-09-30	275.88%
2020-06-30	-120.12%
2020-03-31	-102.08%
2019-12-31	-100.22%
2019-09-30	-149.31%
2019-06-30	-103.08%
2019-03-31	-80.11%
2018-12-31	-57.33%
2018-09-30	-48.30%
2018-06-30	-38.41%
2018-03-31	42.91%
2017-12-31	52.19%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-51.69%
2024-12-31	-99.83%
2023-12-31	-74.63%
2022-12-31	-54.84%
2021-12-31	-33.74%
2020-12-31	-31.88%
2019-12-31	-100.22%
2018-12-31	-57.33%
2017-12-31	52.19%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Gossamer Bio, Inc. (GOSS)	United States	$5.355B	-0.65
Oruka Therapeutics, Inc. (ORKA)	United States	$5.663B	-43.76
PTC THERAPEUTICS, INC. (PTCT)	United States	$5.199B	-177.07
Travere Therapeutics, Inc. (TVTX)	United States	$5.712B	-123.10
Mirum Pharmaceuticals, Inc. (MIRM)	United States	$5.798B	-8.81
Dianthus Therapeutics, Inc. /DE/ (DNTH)	United States	$5.082B	-27.79
Erasca, Inc. (ERAS)	United States	$5.073B	-19.96
Veradermics, Inc (MANE)	United States	$4.839B
Amneal Pharmaceuticals, Inc. (AMRX)		$6.326B	25.62
Liquidia Corp (LQDA)	United States	$6.347B	51.23